
An update from AngioDynamics ( ($ANGO) ) is now available. At its November 17, 2026 Annual Meeting, AngioDynamics shareholders elected Class II directors Eileen O. Auen and Jan Stern Reed
Compare up to 40 stocks
Compared Stocks: 1 / 40
| Ticker | Company Name | Price | Change | % Change | |
|---|---|---|---|---|---|
| ANGO | AngioDynamics | 10.81 | -1.14 | -9.54% |
| Name | Price | % Change | |
|---|---|---|---|
| $10.81 | -9.54% |

An update from AngioDynamics ( ($ANGO) ) is now available. At its November 17, 2026 Annual Meeting, AngioDynamics shareholders elected Class II directors Eileen O. Auen and Jan Stern Reed

AngioDynamics (ANGO) announced two milestones for irreversible electroporation, IRE, the non-thermal ablation technology delivered by the NanoKnife System. The first is the publication of results from the DIRECT study in

AngioDynamics (ANGO) announced that Humana has updated its Medicare Advantage coverage policy to apply Local Coverage Determination L40205 medical necessity criteria for irreversible electroporation, the non-thermal ablation technology delivered by

H.C. Wainwright analyst Yi Chen lowered the firm’s price target on AngioDynamics (ANGO) to $18 from $19 and keeps a Buy rating on the shares. The company reported inline fiscal

Angiodynamics, Inc. (($ANGO)) has held its Q1 earnings call. Read on for the main highlights of the call. AngioDynamics Earnings Call Signals Confidence Amid Challenges. Management struck a decidedly upbeat

Stock futures are lower as a renewed jump in oil prices and Treasury yields revives inflation concerns. Brent crude jumped nearly 5% to above $105 a barrel, while WTI climbed

AngioDynamics ( ($ANGO) ) has issued an update. On October 2, 2026, AngioDynamics’ board appointed industry veteran Eric Honroth as President and CEO and a director, effective November 2, 2026,

AngioDynamics ( ($ANGO) ) has issued an update. For the fiscal first quarter of 2027, ended August 31, 2026, AngioDynamics reported net sales of $80.9 million, up 6.9% year on

Today, several major companies are expected to report earnings: AngioDynamics (ANGO), Helen Of Troy (HELE), Novagold Resources New (NG), Park Electrochemical (PKE), PepsiCo (PEP), Tilray (TLRY). Ahead of earnings, TipRanks

For fiscal 2027, the company expects a tariff impact broadly similar to fiscal 2026, (excluding any tariff refunds) based on its current view of the tariff situation, which remains dynamic
| Name | Upcoming Earnings Date | Market Cap | EPS Forecast | Sales Forecast | PEG Ratio | P/E Ratio |
|---|---|---|---|---|---|---|
| Jan 7, 2027TBA | $454.61M | $-0.07 | $84.19M | -2.06 | -13.68 |
Compare Stocks Side-by-Side
Our stock comparison tool allows investors to compare multiple stocks simultaneously, providing comprehensive insights into key metrics, financial data, and analyst ratings. Make informed investment decisions by analyzing stocks side by side.
Key Features of Our Stock Comparison
How to Use the Stock Comparison Tool
Simply enter the ticker symbols of the stocks you want to compare in the search box above. You can add up to 40 stocks at once. The tool will automatically populate comparison tables with the latest data, allowing you to analyze and contrast different investment opportunities across various sectors and industries.
Popular Stock Comparisons
Investors frequently compare stocks within the same sector to identify the best investment opportunities. Popular comparisons include tech giants like Apple (AAPL) vs. Microsoft (MSFT), semiconductor leaders Nvidia (NVDA) vs. AMD, beverage companies Coca-Cola (KO) vs. Pepsi (PEP), and electric vehicle makers Tesla (TSLA) vs. Rivian (RIVN).
Why Compare Stocks?
Comparing stocks helps investors identify which companies offer the best value, growth potential, and risk-adjusted returns. By analyzing multiple stocks side by side, you can better understand relative valuations, competitive advantages, and market positioning before making investment decisions.